𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TGM2Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer

✍ Scribed by Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Toshiki Hitora; Mitsuyoshi Tei; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori

Book ID
111773399
Publisher
Springer
Year
2009
Tongue
English
Weight
299 KB
Volume
17
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

SCRN1 is a novel marker for prognosis in
SCRN1 is a novel marker for prognosis in colorectal cancer
✍ Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Mitsugu Sekimoto; Yuichiro Doki; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Abstract ## Purpose Secernin 1 (__SCRN1__) is a member of the secernin family and is reported to be a tumor‐associated antigen. Previous reports show that __SCRN1__ is upregulated in gastric cancer cell lines and may be a novel immunotherapy target, whereas its significance in colorectal cancer